Mounjaro: Diabetes Medication for Weight Loss

This is a news story, published by Yahoo, that relates primarily to Zepbound news.

Zepbound news

For more Zepbound news, you can click here:

more Zepbound news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Yahoo news

For more news from Yahoo, you can click here:

more news from Yahoo

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

Mounjaro prescription

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest obesity treatment news, Mounjaro news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

Weight Loss Medication

Verywell Health

•

Can You Take Mounjaro for Weight Loss?

Summary

Nutrition label

69% Informative

Mounjaro (tirzepatide) is a once- weekly injectable medication that the FDA has approved to help manage blood sugar levels in adults with type 2 diabetes.

The FDA has not approved it for weight loss specifically, but it can be prescribed off-label.

In November 2023 , the FDA approved a new drug called Zepbound specifically for weight-loss in people who are obese or overweight with a weight-related condition.

Mounjaro is a once- weekly injectable medicine that can help control blood sugar in people with type 2 diabetes.

Ozempic (semaglutide) is also prescribed off-label for weight management.

In a 40-week study, tirzepatide was more effective at lowering blood sugar levels.

Mounjaro is an injectable medication approved for managing blood sugar in people with type 2 diabetes.

It's not officially approved for weight loss, but it can sometimes be prescribed off-label for this purpose.

Some of the most common side effects of tirzepatide include nausea, vomiting, and diarrhea.

VR Score

Informative language

Neutral language

Article tone

informal

Language